Leukemia Research
Volume 34, Issue 4 , Pages 458-462 , April 2010

Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China

Received 25 April 2009 ,Revised 3 July 2009 ,Accepted 4 July 2009.

References 

  1. Vardiman JW, Imbert M, Pierre R, et al. Chronic myelomonocytic leukemia. In:  Jaffe ES,  Harris NL,  Stein H,  Vardiman JW editor. World Health Organization classification of tumors: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: Lyon IARC Press; 2001;p. 49–52
  2. Subirá D, Font P, Villalón L, et al. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?. Transl Res. 2008;151:240–245
  3. Invernizzi R, Travaglino E, Benatti C, et al. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia. Eur J Haematol. 2006;76:494–501
  4. Wijermans PW, Rüter B, Baer MR, Slack JL, Saba HI, Lübbert M. Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML). Leuk Res. 2008;32:587–591
  5. Kantarjian H, Oki Y, Garcia-Manero G, et al. Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood. 2007;109:52–57
  6. Kantarjian HM, O’Brien S, Huang XL, et al. Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome—comparison with historical experience. Cancer. 2007;109:1133–1137
  7. Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia. 1992;6:52–59
  8. Germing U, Strupp C, Knipp S, et al. Chronic myelomonocytic leukemia in the light of the WHO proposals. Haematologica. 2007;92:974–977
  9. Misialek MJ, Pechet L. A diagnostic dilemma: chronic myelomonocytic leukemia versus atypical chronic myeloid leukaemia. A case report and review of the literature. Acta Haematol. 1997;98:221–227
  10. Orazi A, Chiu R, O’Malley DP, et al. Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology. Mod Pathol. 2006;19:1536–1545
  11. Ngo NT, Lampert IA, Naresh KN. Bone marrow trephine morphology and immunohistochemical findings in chronic myelomonocytic leukaemia. Br J Haematol. 2008;141:771–781
  12. Xu Y, Mckenna RW, Karandikar NJ, Pildain AJ, Kroft HS. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis. Am J Clin Pathol. 2005;124:799–806
  13. Bacher U, Haferlach T, Kern W, Hiddemann W, Schnittger S, Schoch C. Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information. Ann Hematol. 2005;84:250–257
  14. Daskalakis M, Mauritzson N, Johansson B, et al. Trisomy 19 as the sole chromosomal abnormality in proliferative chronic myelomonocytic leukemia. Leuk Res. 2006;30:1043–1047
  15. Germing U, Kundgen A, Gattermann N. Risk assessment in chronic myelomonocytic leukemia (CMML). Leuk Lymphoma. 2004;45:1311–1318
  16. Onida F, Kantarjian HM, Smith TL, et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood. 2002;99:840–849
  17. Stamatoullas A, Waultier A, Callat MP, Penther D, Tilly H, Bastard C. Prognostic factors in chronic myelomonocytic leukaemia: a retrospective analysis of 113 patients. Leuk Res. 2007;31(1):s102
  18. Breccia M, Latagliata R, Mengare A, Biondo F, Mandelli F, Alimena G. Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institution. Haematologica. 2004;89:866–868
  19. Fenaux P, Beuscart R, Lai JL, Jouet JP, Bauters F. Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases. J Clin Oncol. 1988;6:1417–1424
  20. Ribera JM, Cervantes F, Rozman C. A multivariate analysis of prognostic factors in chronic myelomonocytic leukaemia according to the FAB criteria. Br J Haematol. 1987;65:307–311

PII: S0145-2126(09)00352-X

doi: 10.1016/j.leukres.2009.07.011

Leukemia Research
Volume 34, Issue 4 , Pages 458-462 , April 2010

Article Tools

* Image Usage & Resolution